Inactive Instrument

News Spring Pharmaceutical Group, Inc.

Equities

Spring Pharmaceutical Group, Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended December 31, 2018	15/19/15	CI
Spring Pharmaceutical Group, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended September 30, 2018	13/18/13	CI
China YCT International Group, Inc. has Changed its Name to Spring Pharmaceutical Group, Inc	31/18/31	CI
China YCT International Group, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended June 30, 2018	15/18/15	CI
China YCT International Group, Inc Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended September 30, 2017	15/17/15	CI
China YCT International Group, Inc Announces Financial Results for the Year Ending March 31, 2017	12/17/12	CI
China YCT International Group, Inc Appoints Li Dong to the Board of Directors	24/17/24	CI
Shandong Yongchuntang Group Co., Ltd acquired 3% stake in Shandong Spring Pharmaceutical Co., Ltd. from China YCT International Group, Inc.	28/17/28	CI
China YCT International Group Inc. Reports Earnings Results for the Fiscal Year Ended March 31, 2015	16/15/16	CI
CYIG Signs Strategic Cooperation Agreement with Xi'an Putian Pharmacy	15/14/15	CI
China YCT International Group, Inc Reports Earnings Results for the Year Ended March 31, 2014	22/14/22	CI
L.Y.(HK) Biotech Limited cancelled the acquisition of China YCT International Group, Inc in a reverse merger transaction.	29/12/29	CI

No results for this search